Australian researchers, led by Monash University, have invented a new artificial intelligence (AI) tool which is poised to reshape virtual screening in early stage drug discovery and enhance ...

Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results ...

Virtual screening methods for drug discovery typically rely on static structures and lack efficient incorporation of dynamic information exhibited in experimental electron densities.

A new study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics ...

Fischer’s Nanyang Biologics with Nvidia, Hewlett Packard and Equinix to create a leading AI drug discovery platform: Our Bureau, Bengaluru Wednesday, September 3, 2025, 15:15 Hr ...

Artificial intelligence accelerates drug discovery, improving hit identification and clinical trial design while addressing ...

Virtual chemistry speeds up drug discovery Date: January 6, 2025 Source: Scripps Research Institute Summary: Among the hundreds of thousands of chemical compounds produced by plants, some may hold ...

Valinor Discovery, a company pioneering machine learning-powered simulation of therapeutic performance to derisk drug development, today exited stealth to announce their mission to train the first ...

Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Event in the Drug Discovery & Development Virtual Event ...

Submit a research poster to the Drug Discovery & Development Virtual Event Series and enter the 2024 (copy) poster competition for greater visibility to your research.